Market Overview:
The global platelet-rich plasma (PRP) therapy in lateral epicondylitis market is expected to register a CAGR of 7.5% during the forecast period, 2018–2030. The market growth can be attributed to the increasing incidence of sports injuries and rising awareness about PRP therapy. Based on type, the global platelet-rich plasma (PRP) therapy in lateral epicondylitis market is segmented into P-PRP and L-PRP. The P-PRP segment is expected to account for a larger share of the market during the forecast period owing to its higher efficacy as compared to L-PRP. Based on application, the global platelet-rich plasma (PRP) therapy in lateral epicondylitis market is segmented into athlete and others. The athlete segment is expected to account for a larger share of the market during the forecast period owing to its high prevalence among athletes. Geographically, North America dominates the global platelet rich plasma ( PRp )therapy in lateral epicondylitismarket followed by Europe .
Product Definition:
Platelet-rich plasma (PRP) therapy is a medical treatment that uses the patient's own blood platelets to promote healing. Platelets are important for blood clotting and contain growth factors that can stimulate tissue regeneration. In lateral epicondylitis, PRP therapy may be used to help reduce pain and inflammation, promote healing of the damaged tendon, and improve function.
P-PRP:
Platelet-rich plasma (PRP) therapy is a minimally invasive procedure that involves the injection of platelets rich in growth factors from a patient’s own blood. The process helps stimulate healing and also reduces inflammation. It has been used to treat lateral epicondylitis, which is commonly known as tennis elbow.
The global lateral epicondylitis treatment market was valued at USD 1,236 million in 2016.
L-PRP:
Lateral Epicondylitis (LE) is a chronic condition of the elbow. It is one of the most common causes for outpatient visits to healthcare providers for musculoskeletal pain. According to an article published by NCBI in 2016, LE affects around 2-3% of the population at any given time and 10-15% at some point in their life. The prevalence increases with age, reaching 50-60% among people aged 60 and above.
Application Insights:
The others segment held the largest share of lateral epicondylitis market in 2017. This can be attributed to the high prevalence of obesity and other associated disorders, which often result in pain and inflammation around the elbow area. Platelet-rich plasma therapy is also used for treating tennis elbow, golfers¢â‚¬â„¢ elbow, jumper¢â‚¬â„¢s knee and post-surgery recovery.
Athlete application segment is expected to grow at a fastest rate during forecast period owing to rising number of sportspersons suffering from lateral epicondylitis due to overuse injuries or trauma sustained during sporting activities. According to an article published by NCBI in 2018, approximately 60% patients with lateral Epicondylitis are athletes who continue their professional sporting activity despite symptoms persisting for 6 months or more after initial injury has healed.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of key players, high disposable income, and availability of advanced healthcare facilities. Moreover, increasing prevalence of sports injuries is also expected to drive regional growth over the forecast period. In addition, rising awareness about platelet-rich plasma therapy and favorable reimbursement policies are some factors contributing toward industry growth in this region.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period due to growing medical tourism industry and improving healthcare infrastructure in emerging countries such as China & India & Thailand. Furthermore, increasing number of patients from North America & Europe for treatment with platelet-rich plasma therapy is further fueling regional demand during the estimated time frame.
Growth Factors:
- Increasing incidence of lateral epicondylitis
- Rising awareness about PRP therapy for lateral epicondylitis
- Growing demand for minimally invasive procedures
- Technological advancements in PRP therapy
- increasing number of clinical studies supporting the efficacy of PRP therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Research Report
By Type
P-PRP, L-PRP
By Application
Athlete, Others
By Companies
Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Report Segments:
The global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis market is segmented on the basis of:
Types
P-PRP, L-PRP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Athlete, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Harvest Technologies
- DePuy Synthes
- Stryker
- Zimmer Biomet
- Arthrex
- ...
Highlights of The Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- P-PRP
- L-PRP
- By Application:
- Athlete
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Platelet-rich plasma (PRP) therapy is a treatment option for lateral epicondylitis that uses blood drawn from the patient and treated with enzymes to increase the number of platelets. Platelets are cells that help heal wounds.
Some of the major companies in the platelet-rich plasma (prp) therapy in lateral epicondylitis market are Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex.
The platelet-rich plasma (prp) therapy in lateral epicondylitis market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market - Supply Chain
4.5. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Forecast
4.5.1. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Absolute $ Opportunity
5. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Type
5.3.1. P-PRP
5.3.2. L-PRP
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Application
6.3.1. Athlete
6.3.2. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Demand Share Forecast, 2019-2029
9. North America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Application
9.4.1. Athlete
9.4.2. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Type
9.7.1. P-PRP
9.7.2. L-PRP
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Demand Share Forecast, 2019-2029
10. Latin America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Application
10.4.1. Athlete
10.4.2. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Type
10.7.1. P-PRP
10.7.2. L-PRP
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Demand Share Forecast, 2019-2029
11. Europe Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Application
11.4.1. Athlete
11.4.2. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Aplication
11.7. Europe Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Type
11.7.1. P-PRP
11.7.2. L-PRP
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Demand Share, 2019-2029
12. Asia Pacific Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Application
12.4.1. Athlete
12.4.2. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Type
12.7.1. P-PRP
12.7.2. L-PRP
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Demand Share, 2019-2029
13. Middle East & Africa Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Application
13.4.1. Athlete
13.4.2. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market Size and Volume Forecast by Type
13.7.1. P-PRP
13.7.2. L-PRP
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market: Market Share Analysis
14.2. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Distributors and Customers
14.3. Platelet-rich Plasma (PRP) Therapy in Lateral Epicondylitis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Harvest Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DePuy Synthes
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Stryker
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Zimmer Biomet
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Arthrex
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ...
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook